Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History HOTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics HOTH

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Hoth Therapeutics Inc

HOTH
Current price
1.43 USD -0.03 USD (-2.05%)
Last closed 1.44 USD
ISIN US44148G2049
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 19 681 262 USD
Yield for 12 month +62.50 %
1Y
3Y
5Y
10Y
15Y
HOTH
21.11.2021 - 28.11.2021

Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; and HT-004 for treatment of asthma and allergies using inhalational administration. The company is developing BioLexa Platform, a proprietary, patented, drug compound platform in Phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; Isoprene Pharmaceuticals, Inc.; the North Carolina State University; Chelexa BioSciences, Inc. and the University of Cincinnati; Zylö Therapeutics, Inc.; and Voltron Therapeutics, Inc. The company was incorporated in 2017 and is headquartered in New York, New York. Address: 1177 Avenue of the Americas, New York, NY, United States, 10036

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.50 USD

P/E Ratio

Dividend Yield

Financials HOTH

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures HOTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

EBITDA -14 100 397 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -57.15 %
PEG Ratio
Return On Equity TTM -98.26 %
Wall Street Target Price 4.50 USD
Revenue TTM
Book Value 0.88 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.06 USD
Diluted Eps TTM -1.06 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation HOTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.40
Price Book MRQ 1.64

Technical Indicators HOTH

For 52 Weeks

0.58 USD 2.79 USD
50 Day MA 1.08 USD
Shares Short Prior Month 1 151 852
200 Day MA 1.01 USD
Short Ratio 0.50
Shares Short 595 052
Short Percent 8.76 %